Want to see IN:SAILIFE full AI Analyst Report?
SAI Life Sciences Ltd. (SAILIFE) Ratios
SAI Life Sciences Ltd. Ratios
IN:SAILIFE's free cash flow for Q2 2025 was $-1.55B. For the 2025 fiscal year, IN:SAILIFE's free cash flow was decreased by $-2.48B and operating cash flow was $928.35M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.05 | 1.69 | ― | ― | ― |
| Quick Ratio | 1.89 | 1.51 | ― | ― | ― |
| Cash Ratio | 0.12 | 0.13 | ― | ― | ― |
| Solvency Ratio | 0.30 | 0.45 | ― | ― | ― |
| Operating Cash Flow Ratio | 0.38 | 0.62 | ― | ― | ― |
| Short-Term Operating Cash Flow Coverage | 2.16 | 6.98 | ― | ― | ― |
| Net Current Asset Value | $ 4.73B | $ 2.68B | ― | ― | ― |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.08 | ― | ― | ― |
| Debt-to-Equity Ratio | 0.17 | 0.12 | ― | ― | ― |
| Debt-to-Capital Ratio | 0.14 | 0.10 | ― | ― | ― |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | ― | ― | ― |
| Financial Leverage Ratio | 1.48 | 1.46 | ― | ― | ― |
| Debt Service Coverage Ratio | 1.86 | 4.87 | ― | ― | ― |
| Interest Coverage Ratio | 3.49 | 11.83 | ― | ― | ― |
| Debt to Market Cap | 0.01 | 0.00 | ― | ― | ― |
| Interest Debt Per Share | 22.36 | 15.62 | ― | ― | ― |
| Net Debt to EBITDA | 0.59 | 0.26 | ― | ― | ― |
| Profitability Margins | |||||
| Gross Profit Margin | 36.50% | 35.20% | ― | ― | ― |
| EBIT Margin | 17.92% | 23.05% | ― | ― | ― |
| EBITDA Margin | 26.09% | 30.66% | ― | ― | ― |
| Operating Profit Margin | 16.11% | 21.18% | ― | ― | ― |
| Pretax Profit Margin | 13.43% | 21.26% | ― | ― | ― |
| Net Profit Margin | 10.03% | 15.91% | ― | ― | ― |
| Continuous Operations Profit Margin | 10.03% | 15.91% | ― | ― | ― |
| Net Income Per EBT | 74.72% | 74.84% | ― | ― | ― |
| EBT Per EBIT | 83.36% | 100.41% | ― | ― | ― |
| Return on Assets (ROA) | 5.38% | 9.62% | ― | ― | ― |
| Return on Equity (ROE) | 7.99% | 14.05% | ― | ― | ― |
| Return on Capital Employed (ROCE) | 11.25% | 16.63% | ― | ― | ― |
| Return on Invested Capital (ROIC) | 7.80% | 11.85% | ― | ― | ― |
| Return on Tangible Assets | 5.40% | 9.64% | ― | ― | ― |
| Earnings Yield | 1.17% | 1.71% | ― | ― | ― |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.16 | 5.87 | ― | ― | ― |
| Payables Turnover | 3.95 | 4.98 | ― | ― | ― |
| Inventory Turnover | 10.71 | 9.41 | ― | ― | ― |
| Fixed Asset Turnover | 1.05 | 1.05 | ― | ― | ― |
| Asset Turnover | 0.54 | 0.60 | ― | ― | ― |
| Working Capital Turnover Ratio | 3.47 | 3.25 | ― | ― | ― |
| Cash Conversion Cycle | 110.95 | 27.68 | ― | ― | ― |
| Days of Sales Outstanding | 169.35 | 62.20 | ― | ― | ― |
| Days of Inventory Outstanding | 34.09 | 38.78 | ― | ― | ― |
| Days of Payables Outstanding | 92.49 | 73.30 | ― | ― | ― |
| Operating Cycle | 203.44 | 100.98 | ― | ― | ― |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 14.40 | 24.82 | ― | ― | ― |
| Free Cash Flow Per Share | -4.77 | -3.44 | ― | ― | ― |
| Dividend Paid and CapEx Coverage Ratio | 0.75 | 0.88 | ― | ― | ― |
| Capital Expenditure Coverage Ratio | 0.75 | 0.88 | ― | ― | ― |
| Operating Cash Flow Coverage Ratio | 0.79 | 1.81 | ― | ― | ― |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.24 | ― | ― | ― |
| Free Cash Flow Yield | -0.63% | -0.35% | ― | ― | ― |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 85.70 | 58.36 | ― | ― | ― |
| Price-to-Sales (P/S) Ratio | 8.60 | 9.29 | ― | ― | ― |
| Price-to-Book (P/B) Ratio | 6.85 | 8.20 | ― | ― | ― |
| Price-to-Free Cash Flow (P/FCF) Ratio | -158.73 | -282.31 | ― | ― | ― |
| Price-to-Operating Cash Flow Ratio | 52.54 | 39.10 | ― | ― | ― |
| Price-to-Earnings Growth (PEG) Ratio | 0.86 | 0.66 | ― | ― | ― |
| Enterprise Value Multiple | 33.54 | 30.55 | ― | ― | ― |
| Enterprise Value | 148.39B | 205.40B | ― | ― | ― |
| EV to EBITDA | 33.54 | 30.55 | ― | ― | ― |
| EV to Sales | 8.75 | 9.37 | ― | ― | ― |
| EV to Free Cash Flow | -161.58 | -284.77 | ― | ― | ― |
| EV to Operating Cash Flow | 53.48 | 39.44 | ― | ― | ― |
| Tangible Book Value Per Share | 109.92 | 118.09 | ― | ― | ― |
| Shareholders’ Equity Per Share | 110.49 | 118.38 | ― | ― | ― |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.25 | ― | ― | ― |
| Revenue Per Share | 88.03 | 104.50 | ― | ― | ― |
| Net Income Per Share | 8.83 | 16.63 | ― | ― | ― |
| Tax Burden | 0.75 | 0.75 | ― | ― | ― |
| Interest Burden | 0.75 | 0.92 | ― | ― | ― |
| Research & Development to Revenue | 0.00 | 0.00 | ― | ― | ― |
| SG&A to Revenue | 0.03 | 0.14 | ― | ― | ― |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | ― | ― | ― |
| Income Quality | 1.22 | 1.49 | ― | ― | ― |
Currency in INR
